发明名称
摘要 [Problems] To provide a compound which is useful as an NMDA receptor antagonist. [Means for solution] The present inventors have studied a compound having an NMDA receptor antagonistic action, and confirmed that the fused indane compound of the present invention has an excellent NMDA receptor antagonistic action, thereby completed the present invention. The fused indane compound of the present invention has an excellent NMDA receptor antagonistic action and can be used as a prophylactic and/or therapeutic agent for Alzheimer's disease, cerebrovascular dementia, Parkinson's disease, intractable depression, attention deficit hyperactivity disorder, migraines, or the like.
申请公布号 JP5251885(B2) 申请公布日期 2013.07.31
申请号 JP20090543802 申请日期 2008.11.26
申请人 发明人
分类号 C07D209/94;A61K31/403;A61K31/435;A61K31/4365;A61K31/538;A61K31/55;A61P9/10;A61P25/04;A61P25/06;A61P25/16;A61P25/18;A61P25/24;A61P25/28;A61P25/36;A61P43/00;C07D221/16;C07D223/32;C07D265/34;C07D491/048;C07D495/04 主分类号 C07D209/94
代理机构 代理人
主权项
地址